CD274 and neoplasm: Further research on DC vaccines in triple-negative breast cancer has shown an enhanced immune response within the tumor microenvironment, characterized by increased tumor-infiltrating lymphocytes (TILs), elevated PD-L1 expression, and heightened peripheral immune activity, including enhanced lymphocyte proliferation, infiltration, IFN-γ production, and humoral responses [43].